Press Room

Portuguese fine chemicals firm targets big pharma with a plant acquired from Pfizer April 8 was a big day for Hovione, the Portuguese pharmaceutical chemical manufacturer. The family-owned firm, based in the Lisbon suburb of Loures, marked its 50th anniversary and closed on the purchase of a Pfizer chemical plant in Cork, Ireland. Until recently, this plant manufactured the active ingredient in Lipitor, the top-selling drug in the world. Read article here

Article
C&EN, 8 June, 2009

At 50, Hovione Takes A Big Step

Jun 08, 2009

Hovione may have made itself a name as a first-class manufacturer of regulated active pharmaceutical ingredients (APIs), but it still needs to compete on price for some of its business. As in many industries, one of the best ways to lower cost is to have a manufacturing base in China. That is what Hovione did in March 2008 when it acquired a 75% stake in Hisyn Pharmaceutical, an API manufacturer in Taizhou, Zhejiang province. The site is a four-hour drive from Shanghai. Read article here

Article
C&EN, 8 June, 2009

Hovione Shapes China Manufacturing Site

Jun 08, 2009

Contrary to what some would have you believe, the use of substandard APIs in European medicines puts patient health and pharmaceutical manufacturers' reputations at risk. Most APIs destined for the EU come from Asian plants that have never been inspected by an EU official. To ensure a minimum level of quality, agencies and regulators from both sides of the Atlantic must work together to provide API compliance oversight. Read article here

Article
Pharmaceutical Technology Europe, June, 2009

Substandard APIs: we must tackle the problem together

Jun 01, 2009

PharmaChemical Ireland is the leading representative body for the pharmaceutical and chemical manufacturing sectors in Ireland. A major business association within the Irish Business and Employers Confederation (IBEC), PharmaChemical Ireland has access to IBEC’s core support and research facilities, and has a full-time executive staff. We represent the manufacturers and distributors of pharmaceutical products and ingredients, and general chemical materials. Our membership is composed of leading global corporations and indigenous Irish companies. Nine of the top ten pharmaceutical corporations in the world have manufacturing plants in Ireland. Read article here

Article
PharmaChemical Ireland Presentation, April 2009

Why Ireland should be your location of choice

Apr 01, 2009

Private companies usually have their shareholders meet every Sunday lunch, shop talk is kept to a minimum so as not to offend the “in-laws” and siblings not involved in the business. Family owned companies are involved in management and get remunerated by far more than just dividends. The reputation that comes with a company that does well, that is a highly sought-after employer, that leads in innovation, in environmental thinking and international expansion, that does things right - rubs onto the family. For a family to be leading a business that is a role model brings a non-monetary compensation that makes this tight-knit group far richer than any stock market investor could ever be. Can you imagine the pride of a family where the business it owns addresses the capacity needs for the only paediatric HIV protease inhibitor? or the most innovative (avian) flu medicine? Full version of Family owned businesses article

Article
Chemistry Today, December 2008

Family Owned Businesses

Dec 01, 2008

Why this presentation? Almost 100 deaths have been traced to counterfeit heparin, probably a better data collection system would establish that many hundreds are now dead – not because of a regulatory failure but because of greed. Crime has been committed with premeditation and with recourse to science and industrial means – and nobody spells it out. and nobody spells it out. Did someone make millions in profit, and poisoned to death hundreds of weak, defenseless patients? hundreds of weak, defenseless patients? Is a police investigation underway? Penny wise, pound foolish – these events cost / will cost billions to several big companies – and damaged brands. Where a drug begins...  

Article
3rd EFCG Pharma Business Conference, 29 May 2008

Business of Counterfeit Heparin and its Implications

May 29, 2008

Independent Portuguese APIs producer Hovione has bought 75% of Hisyn Pharmaceutical in China's Zhejiang province, which had been supplying it with intermediates for some time. This transaction is already operational after the Zhejiang authorities issued the necessary business licence. With this buy come development laboratories in Shanghai and a 22,000m2 API facility on a nine-hectare plot, employing 181. Hovione will produce its two largest volume products here. The company said that the deal gives it...

Article
Speciality Chemicals, April 2008

Hovione buys first site in China

Apr 01, 2008

Contact Us

If you would like to learn more about Hovione, kindly fill in the form below and we will be revert to you soon.

By clicking Submit, you agree to our Terms and that you have read our Privacy Notice, including our Cookie use.